Table 2 Retrospective cohort description
From: Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer
Variable | Group | N | % of cohort (%) |
|---|---|---|---|
Age | [30, 40) | 1 | 0.4 |
[40, 50) | 5 | 2.0 | |
[50, 60) | 40 | 16.0 | |
[60, 70) | 105 | 42.0 | |
[70, 80) | 75 | 30.0 | |
[80, 90) | 23 | 9.2 | |
[90, 100) | 1 | 0.4 | |
Sex | Female | 136 | 54.4 |
Male | 114 | 45.6 | |
Tumor type | NSCLC | 250 | 100.0 |
Histology type | Non-squamous | 213 | 85.2 |
Squamous | 37 | 14.8 | |
Treatment group | Pembro. + chemo | 148 | 59.2 |
Pembrolizumab | 102 | 40.8 | |
All samples | 250 | 100.0 | |